These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3570156)

  • 1. The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability.
    Lo WD; Ennis SR; Goldstein GW; McNeely DL; Betz AL
    Hepatology; 1987; 7(3):452-6. PubMed ID: 3570156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.
    Knudsen GM; Poulsen HE; Paulson OB
    J Hepatol; 1988 Apr; 6(2):187-92. PubMed ID: 3411098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased blood-brain transfer in a rabbit model of acute liver failure.
    Horowitz ME; Schafer DF; Molnar P; Jones EA; Blasberg RG; Patlak CS; Waggoner J; Fenstermacher JD
    Gastroenterology; 1983 May; 84(5 Pt 1):1003-11. PubMed ID: 6832551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies of blood brain barrier permeability in acute hepatic failure.
    Zaki AE; Ede RJ; Davis M; Williams R
    Hepatology; 1984; 4(3):359-63. PubMed ID: 6373548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats.
    Zeneroli ML; Iuliano E; Racagni G; Baraldi M
    J Neurochem; 1982 May; 38(5):1219-22. PubMed ID: 7062047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure.
    Chastre A; Bélanger M; Nguyen BN; Butterworth RF
    Liver Int; 2014 Mar; 34(3):353-61. PubMed ID: 23910048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
    Ede RJ; Gove CD; Hughes RD; Marshall W; Williams R
    Clin Sci (Lond); 1987 Mar; 72(3):365-71. PubMed ID: 3028700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electron microscopic study of the blood-brain barrier in rats with brain edema and encephalopathy due to acute hepatic failure.
    Kato M; Sugihara J; Nakamura T; Muto Y
    Gastroenterol Jpn; 1989 Apr; 24(2):135-42. PubMed ID: 2744330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An electron microscopic histochemical study of the blood-brain barrier in acute hepatic failure induced by D-galactosamine].
    Fujita S
    Nihon Ika Daigaku Zasshi; 1987 Jun; 54(3):290-9. PubMed ID: 3611303
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of hepatic ischemia-reperfusion injury on the blood-brain barrier permeability to [
    Miah MK; Bickel U; Mehvar R
    Metab Brain Dis; 2017 Dec; 32(6):1903-1912. PubMed ID: 28779418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier.
    Traber PG; Dal Canto M; Ganger DR; Blei AT
    Hepatology; 1987; 7(6):1272-7. PubMed ID: 3679092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
    Wang F; Niu Z; Li ZM
    Chin Med J (Engl); 1990 Mar; 103(3):197-200. PubMed ID: 2114962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
    Dixit V; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of fulminant hepatic failure in the rat.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential toxins of acute liver failure and their effects on blood-brain barrier permeability.
    Zaki AE; Wardle EN; Canalese J; Ede RJ; Williams R
    Experientia; 1983 Sep; 39(9):988-91. PubMed ID: 6884496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hepatic failure toxins on regenerative enzymes in the liver after injury with galactosamine in the rat.
    Zieve L; Dozeman R
    J Lab Clin Med; 1989 Apr; 113(4):463-8. PubMed ID: 2703758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
    Yamada A; Takeuchi H; Miki H; Touge T; Nishioka M
    No To Shinkei; 1992 Feb; 44(2):103-9. PubMed ID: 1567728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of regenerating liver cytosol on drug-induced hepatic failure.
    Ohkawa M; Hayashi H; Chaudry IH; Clemens MG; Baue AE
    Surgery; 1985 Apr; 97(4):455-62. PubMed ID: 3983821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure.
    McClung HJ; Sloan HR; Powers P; Merola AJ; Murray R; Kerzner B; Pollack JD
    Pediatr Res; 1990 Sep; 28(3):227-31. PubMed ID: 2235119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.